首药控股股价跌5.09%，国泰基金旗下1只基金重仓，持有2.62万股浮亏损失5.5万元

Group 1 - The core point of the news is that Shouyao Holdings experienced a decline of 5.09% in its stock price, reaching 39.13 yuan per share, with a total market capitalization of 5.819 billion yuan as of the report date [1] - Shouyao Holdings, established on April 19, 2016, and listed on March 23, 2022, is primarily engaged in the research and development of small molecule anti-tumor drugs, with 100% of its revenue coming from technology development and services [1] Group 2 - From the perspective of fund holdings, Guotai Fund has a significant position in Shouyao Holdings through its fund Guotai Innovation Medical Mixed Initiation A (018159), which held 26,200 shares, accounting for 4.77% of the fund's net value, making it the eighth largest holding [2] - The fund Guotai Innovation Medical Mixed Initiation A was established on April 18, 2023, with a latest scale of 17.7778 million yuan, and has achieved a year-to-date return of 49.23%, ranking 1171 out of 8148 in its category [2] - The fund manager, Qiu Xiaoxu, has a tenure of 3 years and 85 days, with the fund's total asset size at 676 million yuan, achieving a best return of 14.1% and a worst return of 1.44% during his management period [2]